This compound is a modified nucleoside derivative used as a pharmaceutical intermediate in the synthesis of nucleoside analogs. It features a benzoyl-protected amino group and a methyl substituent on the cytosine ring, along with a deoxyribose sugar moiety.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 104579-02-4
5'-O-DMT-2'-O-TBDMS-Pseudouridine
pharmaceutical intermediate
N-Acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluorocytidine
pharmaceutical intermediate
Beta-D-Ribofuranose 1,2,3,5-tetraacetate
pharmaceutical intermediate
1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-L-Lyxofuranose
pharmaceutical intermediate
N-Benzoyl-5'-O-(bis(4-methoxyphenyl)phenylmethyl)-2'-deoxy-5-methylcytidine
pharmaceutical intermediate
2-Hydroxy-3-methoxy-3,3-diphenylpropanoic Acid-d3 Methyl Ester
pharmaceutical intermediate
2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole
pharmaceutical intermediate
6-Acetamido-2-amino-4,5,6,7-tetrahydrobenzothiazole
pharmaceutical intermediate
N-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
VYJDMDIVDHHLGK-BFHYXJOUSA-N
CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)[C@H]3C[C@@H]([C@H](O3)CO)O
—